Stock Events

Stock Events

Search...

Madrigal Pharmaceuticals (MDGL) Q2 2024 Earnings

7MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-7.38

-6.45

-5.51

-4.58

Details

Expected EPS

-6.285012

Actual EPS

-7.38

Surprise EPS

-1.09

Surprise Percent

+17.42%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -7.38 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.